eltrombopag olamine

Italy

Drugs containing this active substance

  • ELREVOLAN

    It is used to help increase the number of platelets in the blood. It is indicated for the treatment of immune thrombocytopenia (ITP) in patients who have not responded to other medications and for the treatment of low platelet counts in patients with hepatitis C virus.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag olamine -

    ATC: B02BX05

    Manufacturer: G.L. PHARMA GMBH

  • It is used to help increase the number of platelets in the blood. It is indicated for the treatment of immune thrombocytopenia (ITP) in patients who have not responded to other medications and for the treatment of low platelet counts in patients with hepatitis C who have had adverse reactions to interferon.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag olamine -

    ATC: B02BX05

    Manufacturer: Abdi Farma GmbH

  • It is used to help increase the number of platelets in the blood. It is indicated for the treatment of immune thrombocytopenia (primary) in patients over 1 year of age who have not responded to other medicines, and for the treatment of low platelet counts in patients with hepatitis C virus who have had adverse reactions to interferon.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag olamine -

    ATC: B02BX05

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • The drug is indicated for the treatment of adults with immune thrombocytopenia (ITP) who have not responded to other treatments. It is also indicated for children over 1 year of age with the same condition (if present for at least 6 months) and for adults with chronic hepatitis C virus infection presenting with a low platelet count.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag olamine -

    ATC: B02BX05

    Manufacturer: CIPLA EUROPE NV

  • It is used to help increase the number of platelets in the blood. It is indicated for the treatment of immune thrombocytopenia (primary) in patients aged 1 year and older who have not responded to other medications, and for the treatment of low platelet count in adults with hepatitis C virus (HCV) infection who have had problems with interferon-based treatment.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag olamine -

    ATC: B02BX05

    Manufacturer: DR. REDDY'S S.R.L.

  • It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients who have not responded to other medicines, for low platelet counts in adults with hepatitis C, and for low blood cell counts caused by severe aplastic anemia (SAA).

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag olamine -

    ATC: B02BX05

    Manufacturer: EG S.P.A.

  • This medicine is used to increase the number of platelets in the blood. It is used to treat immune thrombocytopenia (primary) in patients who have not responded to other treatments, and for low platelet counts in patients with hepatitis C.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag olamine -

    ATC: B02BX05

    Manufacturer: GLENMARK ARZNEIMITTEL GMBH

  • It is used to increase the number of platelets in the blood. It is indicated for the treatment of immune thrombocytopenia (primary) in patients who have not responded to other drugs and for the treatment of low platelet counts in patients with hepatitis C virus who have had adverse reactions to interferon.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag olamine -

    ATC: B02BX05

    Manufacturer: KRKA D.D. NOVO MESTO

  • It is used to increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients aged 1 year and older who have not responded to other medicines, and to treat low platelet counts in adults with hepatitis C virus (HCV) infection who have experienced adverse effects with interferon.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag olamine -

    ATC: B02BX05

    Manufacturer: TEVA ITALIA S.R.L.

  • It is used to increase the number of platelets in the blood. It is indicated for the treatment of immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other medications, and for the treatment of low platelet counts in patients with hepatitis C virus.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag olamine -

    ATC: B02BX05

    Manufacturer: ZENTIVA ITALIA S.R.L.

  • It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients aged 1 year and older who have not responded to other medicines, and for the treatment of low platelet counts in adult patients with hepatitis C who have had adverse reactions to interferon treatment.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag olamine -

    ATC: B02BX05

    Manufacturer: TILLOMED ITALIA SRL